Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Dr. Will Bulsiewicz explains the importance of spacing meals apart to improve gut health, enhance digestion, and align with natural body rhythms.

The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class ...

Weight loss treatments Mounjaro and Zepbound are the primary growth engines for Eli Lilly right now, but the company has ...

With with GLP-1 drugs, gastrointestinal issues, such as nausea, vomiting, constipation, and gastroesophageal reflux disease, ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

Underrepresentation of women as participants and researchers in CV clinical trials remains a problem, asserts a review ...

Oprah Winfrey is sparking a debate around weight, willpower and perception after the media mogul revealed her perceptions ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

In the trial, patients who received a once-weekly 20 mg injection of amycretin over 36 weeks saw an impressive 22% reduction ...

For people with diabetes, the use of GLP-1 RAs is associated with reduced risk for certain disorders and conditions.